Evid Invest
Holders — by stockHoldings — by fund

IvyRock Asset Management (HK) Ltd

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001809525

$176.9M

disclosed book value

25

positions

50.6%

largest position share

Positions, as of 2026-06-30

top 25 of 25 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1PDDPDD HOLDINGS INC1.2M$89.6M50.6%
2BABAALIBABA GROUP HLDG LTD246,700$23.7M13.4%
3LEGNLEGEND BIOTECH CORP801,000$23.1M13.1%
4CRCLCIRCLE INTERNET GROUP INC283,500$17.8M10%
5IBITISHARES BITCOIN TRUST ETF246,400$8.2M4.6%
6BEKEKE HLDGS INC360,000$5.2M3%
7HUYAHUYA INC1.0M$2.4M1.4%
8GLDSPDR GOLD SHARES3,000$1.1M0.6%
9AMDADVANCED MICRO DEVICES1,000$580,9100.3%
10ARWRARROWHEAD PHARMACEUTICALS IN7,000$570,5700.3%
11NOWSERVICENOW INC5,500$546,0400.3%
12CSCOCISCO SYS INC4,500$528,5700.3%
13MDBMONGODB INC1,300$436,6700.2%
14COPXGLOBAL X FDS5,000$384,8500.2%
15MSFTMICROSOFT CORP1,000$373,0200.2%
16SNPSSYNOPSYS INC800$356,8560.2%
17SOXLDIREXION SHARES ETF TRUST1,300$346,7230.2%
18JOYYJOYY INC5,000$329,9500.2%
19BEAMBEAM THERAPEUTICS INC8,600$295,1520.2%
20SILGLOBAL X FDS3,500$271,1100.2%
21URNMSPROTT FDS TR4,000$210,3600.1%
22NTLAINTELLIA THERAPEUTICS INC10,000$169,2000.1%
23DHT HOLDINGS INC10,000$165,3000.1%
24PRMEPRIME MEDICINE INC41,800$154,2420.1%
25REREATRENEW INC20,000$77,4000%

Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.